Evertz Technologies Earnings Calls
| Release date | Jun 24, 2026 |
| EPS estimate | $0.142 |
| EPS actual | $0.147 |
| EPS Surprise | 3.88% |
| Revenue estimate | 96.125M |
| Revenue actual | 96.795M |
| Revenue Surprise | 0.697% |
| Release date | Mar 04, 2026 |
| EPS estimate | $0.173 |
| EPS actual | $0.176 |
| EPS Surprise | 1.73% |
| Revenue estimate | 101.706M |
| Revenue actual | 102.257M |
| Revenue Surprise | 0.542% |
| Release date | Dec 10, 2025 |
| EPS estimate | $0.132 |
| EPS actual | $0.173 |
| EPS Surprise | 30.83% |
| Revenue estimate | 91.292M |
| Revenue actual | 94.697M |
| Revenue Surprise | 3.73% |
| Release date | Sep 09, 2025 |
| EPS estimate | $0.0986 |
| EPS actual | $0.112 |
| EPS Surprise | 13.75% |
| Revenue estimate | 124.554M |
| Revenue actual | 81.393M |
| Revenue Surprise | -34.65% |
Last 4 Quarters for Evertz Technologies
Below you can see how EVTZF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 09, 2025 |
| Price on release | $8.82 |
| EPS estimate | $0.0986 |
| EPS actual | $0.112 |
| EPS surprise | 13.75% |
| Date | Price |
|---|---|
| Sep 03, 2025 | $8.82 |
| Sep 04, 2025 | $8.82 |
| Sep 05, 2025 | $8.82 |
| Sep 08, 2025 | $8.82 |
| Sep 09, 2025 | $8.82 |
| Sep 10, 2025 | $8.82 |
| Sep 11, 2025 | $8.82 |
| Sep 12, 2025 | $8.82 |
| Sep 15, 2025 | $8.82 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Dec 10, 2025 |
| Price on release | $9.64 |
| EPS estimate | $0.132 |
| EPS actual | $0.173 |
| EPS surprise | 30.83% |
| Date | Price |
|---|---|
| Dec 04, 2025 | $9.64 |
| Dec 05, 2025 | $9.64 |
| Dec 08, 2025 | $9.64 |
| Dec 09, 2025 | $9.64 |
| Dec 10, 2025 | $9.64 |
| Dec 11, 2025 | $10.60 |
| Dec 12, 2025 | $10.92 |
| Dec 15, 2025 | $10.61 |
| Dec 16, 2025 | $10.61 |
| 4 days before | 0% |
| 4 days after | 10.06% |
| On release day | 9.96% |
| Change in period | 10.06% |
| Release date | Mar 04, 2026 |
| Price on release | $11.75 |
| EPS estimate | $0.173 |
| EPS actual | $0.176 |
| EPS surprise | 1.73% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $11.74 |
| Feb 27, 2026 | $11.74 |
| Mar 02, 2026 | $11.74 |
| Mar 03, 2026 | $11.75 |
| Mar 04, 2026 | $11.75 |
| Mar 05, 2026 | $11.75 |
| Mar 06, 2026 | $11.75 |
| Mar 09, 2026 | $11.78 |
| Mar 10, 2026 | $11.78 |
| 4 days before | 0.0852% |
| 4 days after | 0.255% |
| On release day | 0% |
| Change in period | 0.341% |
| Release date | Jun 24, 2026 |
| Price on release | $11.64 |
| EPS estimate | $0.142 |
| EPS actual | $0.147 |
| EPS surprise | 3.88% |
| Date | Price |
|---|---|
| Jun 17, 2026 | $11.64 |
| Jun 18, 2026 | $11.64 |
| Jun 22, 2026 | $11.64 |
| Jun 23, 2026 | $11.64 |
| Jun 24, 2026 | $11.64 |
| Jun 25, 2026 | $11.64 |
| Jun 26, 2026 | $11.64 |
| Jun 29, 2026 | $11.64 |
| Jun 30, 2026 | $13.99 |
| 4 days before | 0% |
| 4 days after | 20.19% |
| On release day | 0% |
| Change in period | 20.19% |
Evertz Technologies Earnings Call Transcript Summary of Q2 2026
Evertz reported Q2 FY2026 revenue of $132.7M, up 6% year-over-year and +18.4% sequentially. Recurring Software & Services totaled $60.7M (≈46% of revenue), a key growth driver and a trailing-12-month recurring run-rate of about $224M (≈44% of trailing revenue). Gross margin was 58.6% (within the 56%–60% target range) and diluted EPS was $0.24. R&D remained a major investment at $36.6M for the quarter (27.6% of revenue). Cash on hand was $96.7M and working capital $205.7M. The company finished November with >$240M purchase order backlog and $46M of shipments during November (combined shipments + backlog >$286M). The Board declared the regular quarterly dividend ($0.205/share) and a special dividend ($1.00/share), both payable ~Dec 24; the NCIB was renewed (effective Dec 11). Management emphasized continued momentum driven by adoption of IP/IT/cloud video solutions (ENX, DreamCatcher/BRAVO Studio), large-scale deployments, and ongoing investment in R&D and manufacturing expansion (facility acquisition near Pittsburgh). They noted margin variability is driven primarily by product mix, that ~60% of backlog is expected to convert within 12 months, and that most products sold are currently USMCA-compliant while the company is expanding U.S. manufacturing capacity to mitigate potential tariff risk. No debt was reported and the company said it retains flexibility for M&A.
Sign In
Buy EVTZF